SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Mar-23 6:00 PM View: | Iterum Therapeutics Plc (ITRM) | 11-Mar-23 | Grant | 6,666 | -- | -- | 153% 4.35K to 11.02K | |
14-Mar-23 6:00 PM View: | Iterum Therapeutics Plc (ITRM) | 11-Mar-23 | Payment of Exercise | 2,883 | $0.96 | $2,767.68 | (26%) 11.02K to 8.13K | |
15-Mar-22 5:01 PM View: | Iterum Therapeutics Plc (ITRM) | 14-Mar-22 | Sale | 47,132 | $0.38 | $17,910.20 | (37%) 128.63K to 81.5K | |
15-Mar-22 5:01 PM View: | Iterum Therapeutics Plc (ITRM) | 11-Mar-22 | Grant | 100,000 | -- | -- | 349% 28.63K to 128.63K | |
27-Jan-21 7:32 PM View: | Iterum Therapeutics Plc (ITRM) | 26-Jan-21 | Market Sale | 33,868 | $1.73 | $58,591.60 | (54%) 62.5K to 28.63K | 18% |
27-Jan-21 7:32 PM View: | Iterum Therapeutics Plc (ITRM) | 25-Jan-21 | Grant | 62,500 | -- | -- | 100% 0 to 62.5K | |
02-Oct-20 9:00 PM View: | Iterum Therapeutics Plc (ITRM) | 30-Sep-20 | Market Sale (Planned) | 56,130 | $1.64 | $92,053.20 | (100%) 56.13K to 0 | 12% |
30-May-18 10:00 PM View: | Iterum Therapeutics Plc (ITRM) | 30-May-18 | Conversion | 16,484 | -- | -- | 46% 35.65K to 52.13K | |
30-May-18 10:00 PM View: | Iterum Therapeutics Plc (ITRM) | 30-May-18 | Purchase | 4,000 | $13.00 | $52,000.00 | 8% 52.13K to 56.13K |